Research and Development

Former Sanofi-Aventis UK chairman and managing director Nigel Brooksby has joined Cheshire, UK-based Prism Ideas as non-executive chairman. The medical …

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …

Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …

Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …